Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) was the target of a significant decline in short interest in June. As of June 15th, there was short interest totalling 104,500 shares, a decline of 56.8% from the May 31st total of 241,900 shares. Based on an average daily volume of 71,400 shares, the days-to-cover ratio is […]
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Rating) was the recipient of a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling 241,900 shares, a drop of 11.4% from the May 15th total of 272,900 shares. Based on an average trading volume of 71,300 shares, the […]
Shares of Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Rating) have earned a consensus rating of “Buy” from the eight research firms that are covering the stock, MarketBeat.com reports. Eight investment analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokers that have issued ratings on the stock in […]
Shares of Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Rating) have earned an average rating of “Buy” from the eight research firms that are currently covering the company, Marketbeat reports. Eight investment analysts have rated the stock with a buy recommendation. The average 1-year target price among brokers that have covered the stock in the last […]